Thomas E. D’Ambra, Ph.D. co-founded Albany Molecular Research, Inc. in 1991 and served as President and Chief Executive Officer until his retirement in 2013. During his leadership tenure with the Company and until 2012, Dr. D’Ambra also served as the Chairman of the Board. As of January 2014, Dr. D’Ambra resumed the role of Chairman of the Board.
During his tenure as an employee of the Company, Dr. D'Ambra had been involved and taken an active role in all aspects of the Company’s business at various times, from bench research scientist to business development, to operational and strategic management and led the Company in its Global growth through 2013. He has authored numerous publications and is inventor on over 30 U.S. patents. He has and continues to serve as an advisor and mentor for new and young companies.
Prior to co-founding the Company, Dr. D’Ambra served as the Vice President, Chemistry and co-founder of Coromed, Inc., a traditional development contract research organization, from 1989 to 1991 and Group Leader and Senior Research Chemist with Sterling Winthrop, Inc., a pharmaceutical company, from 1982 to 1989.
In August 2014, Dr. D'Ambra was appointed to the Albany College of Pharmacy and Health Sciences' (ACPHS) Board of Trustees and in October 2014 was appointed to the Albany Palace Theater and Performance Arts Center Board of Trustees.